Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether RX-1741, an oxazolidinone antibiotic, is
safe and effective in the treatment of mild to moderate community acquired pneumonia (CAP).